A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Bioavailability, and Food-effects of EA1080 in Healthy Caucasian and Japanese Male Participants
Clinical trial NCT04223960 · COMPLETED
Trial details
- NCT number
- NCT04223960
- Sponsor
- EA Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-09
- Primary completion
- 2023-08-06
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.